Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Liebing, S; Dalkner, N; Ischebeck, A; Bengesser, SA; Birner, A; Fellendorf, FT; Lenger, M; Maget, A; Kroisenbrunner, H; Häussl, A; Platzer, M; Queissner, R; Schönthaler, EMD; Stross, T; Tmava-Berisha, A; Reininghaus, EZ.
A one-year view on the association of metabolic syndrome and cognitive function in bipolar disorder - Preliminary data.
J Affect Disord. 2023; 323:251-256
Doi: 10.1016/j.jad.2022.11.067
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Dalkner Nina
- Co-Autor*innen der Med Uni Graz
- Bengesser Susanne
- Birner Armin
- Fellendorf Frederike
- Häussl Alfred Alois
- Lenger Melanie
- Maget Alexander
- Platzer Martina
- Queissner Robert
- Reininghaus Eva
- Schönthaler Elena
- Stross Tatjana Maria
- Tmava-Berisha Adelina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Individuals with bipolar disorder have a high prevalence of metabolic syndrome and an increased risk for cognitive deficits. The aim of this longitudinal study was to investigate the trajectory of cognitive decline in dependence of metabolic syndrome over a one-year interval. METHODS: 52 well-diagnosed individuals with bipolar disorder, euthymic at baseline and follow-up (n = 17 with metabolic syndrome vs. n = 35 without metabolic syndrome) were investigated with a comprehensive neurocognitive test battery (Trail Making Test A/B, Digit Symbol Test, California Verbal Leaning Test, or the Verbal Learning and Memory Test respectively) twice within the interval of one year. RESULTS: Patients with bipolar disorder and additional metabolic syndrome performed significantly worse in the domain of psychomotor and processing speed/attention than patients without metabolic syndrome at test point one. No deteriorating effects of metabolic syndrome on the cognitive domain scores and overall cognitive performance were found at the one-year follow up. However, no cognitive decline could be reported in both groups. LIMITATIONS: Time interval, small sample size and selection of metabolic syndrome affected patients were the major limitations of this study. CONCLUSION: There was no association of metabolic syndrome on the one-year trajectory of cognitive function in bipolar disorder. Future studies should expand the observation period and investigate larger samples.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Bipolar Disorder - complications, epidemiology
- Longitudinal Studies - administration & dosage
- Metabolic Syndrome - complications, epidemiology
- Preliminary Data - administration & dosage
- Neuropsychological Tests - administration & dosage
- Cognition - administration & dosage
- Find related publications in this database (Keywords)
- Bipolar disorder
- Cognition Metabolic syndrome
- Processing speed/attention
- Verbal learning
- Executive functions